![Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis | Scientific Reports Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-68011-4/MediaObjects/41598_2020_68011_Fig1_HTML.png)
Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis | Scientific Reports
![Here Are the Scoring Charts for the Air Force's New PT Test Exercises—Minus the Walk | Air & Space Forces Magazine Here Are the Scoring Charts for the Air Force's New PT Test Exercises—Minus the Walk | Air & Space Forces Magazine](https://www.airforcemag.com/app/uploads/2021/11/Scoring_the_New_Fitness_Test.png)
Here Are the Scoring Charts for the Air Force's New PT Test Exercises—Minus the Walk | Air & Space Forces Magazine
![Risk factors and vectors for SARS-CoV-2 household transmission: a prospective, longitudinal cohort study - The Lancet Microbe Risk factors and vectors for SARS-CoV-2 household transmission: a prospective, longitudinal cohort study - The Lancet Microbe](https://www.thelancet.com/cms/asset/2305b28b-9959-4384-822a-5f5e3edb09b1/gr1.jpg)
Risk factors and vectors for SARS-CoV-2 household transmission: a prospective, longitudinal cohort study - The Lancet Microbe
![The psychological impact of quarantine and how to reduce it: rapid review of the evidence - The Lancet The psychological impact of quarantine and how to reduce it: rapid review of the evidence - The Lancet](https://www.thelancet.com/cms/attachment/1505ef3f-4ec1-42f6-9370-86fe3df69ab8/gr1.gif)
The psychological impact of quarantine and how to reduce it: rapid review of the evidence - The Lancet
![Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023 | MMWR Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023 | MMWR](https://www.cdc.gov/mmwr/volumes/72/wr/social-media/mm7205e3_CurrentVariants_Immunocompromised_IMAGE_27Jan2023_1200x675_1.jpg?_=59980)